Literature DB >> 29287968

DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223.

Jorge D Ramos1, Elahe A Mostaghel1, Colin C Pritchard2, Evan Y Yu3.   

Abstract

Keywords:  Alkaline phosphatase; BRCA2; Biomarker; CHEK2; Genetic sequencing

Mesh：

Substances：

Year:  2017        PMID： 29287968     DOI： 10.1016/j.clgc.2017.11.009

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  3 in total

1.  Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.

Authors:  Pedro Isaacsson Velho; Fahad Qazi; Sayeedul Hassan; Michael A Carducci; Samuel R Denmeade; Mark C Markowski; Daniel L Thorek; Theodore L DeWeese; Daniel Y Song; Phuoc T Tran; Mario A Eisenberger; Emmanuel S Antonarakis
Journal:  Eur Urol       Date:  2018-10-04       Impact factor: 20.096

2.  Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.

Authors:  Oliver Sartor; Daniel Heinrich; Neil Mariados; Maria José Méndez Vidal; Daniel Keizman; Camilla Thellenberg Karlsson; Avivit Peer; Giuseppe Procopio; Stephen J Frank; Kalevi Pulkkanen; Eli Rosenbaum; Stefano Severi; José Trigo; Lucia Trandafir; Volker Wagner; Rui Li; Luke T Nordquist
Journal:  Prostate       Date:  2019-08-23       Impact factor: 4.104

Review 3.  Radium-223 mechanism of action: implications for use in treatment combinations.

Authors:  Michael J Morris; Eva Corey; Theresa A Guise; James L Gulley; William Kevin Kelly; David I Quinn; Arne Scholz; George Sgouros
Journal:  Nat Rev Urol       Date:  2019-11-11       Impact factor: 14.432
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.